Endocrinology, Vol 137, 4857-4863, Copyright © 1996 by Endocrine Society

ARTICLES

Interleukin-6 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles

K Yamazaki, E Yamada, Y Kanaji, K Shizume, DS Wang, N Maruo, T Obara and K Sato
Kanaji Hospital, Tokyo, Japan.

Interleukin-6 (IL-6), a pleiotropic cytokine, is postulated to be involved in the pathogenesis of sick euthyroid syndrome, although the direct in vitro effects of IL-6 on human thyroid function are controversial. Because IL-6 signal can be transduced when the complex of IL-6 and soluble IL-6 receptor (sIL-6R) binds to gp 130, an IL-6 signal transducer, we studied the effects of IL-6 and sIL-6R on thyroid function, using human thyroid follicles obtained from patients with Graves' disease. IL-6 alone had no inhibitory effect on TSH-induced thyroid function (125I incorporation and organic 125I release), even at supraphysiological concentrations. However, in the presence of physiological concentrations of sIL-6R (100 ng/ml), IL-6 inhibited thyroid function dose dependently and completely, accompanied with the decreased ratio of 125I-T3/125I-T4 not only in the thyroid follicles but also in the culture medium. Thyroid follicles did not secrete sIL- 6R but produced IL-6 constitutively. Consistent with these findings, sIL-6R inhibited thyroid function slightly at high concentrations. Furthermore, RT-PCR analyses revealed that human thyroid follicles expressed the messenger RNAs for IL-6 and gp130 but scarcely messenger RNA for IL-6R. These in vitro findings suggest that IL-6 alone hardly affects thyroid function in thyroid follicles in which IL-6R gene is scarcely expressed. However, because sIL-6R is present abundantly in serum, IL-6 in vivo would be capable of inhibiting the synthesis and release of T4 and, to a greater extent, T3 from the thyroid gland. These in vitro findings are at least partly related to the development of sick euthyroid syndrome.

This article has been cited by other articles:

				K. Yamazaki, K. Suzuki, E. Yamada, T. Yamada, F. Takeshita, M. Matsumoto, T. Mitsuhashi, T. Obara, K. Takano, and K. Sato Suppression of Iodide Uptake and Thyroid Hormone Synthesis with Stimulation of the Type I Interferon System by Double-Stranded Ribonucleic Acid in Cultured Human Thyroid Follicles Endocrinology, July 1, 2007; 148(7): 3226 - 3235. [Abstract] [Full Text] [PDF]

				S. Yoshida, T. Harada, T. Iwabe, F. Taniguchi, M. Mitsunari, N. Yamauchi, I. Deura, S. Horie, and N. Terakawa A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis Hum. Reprod., August 1, 2004; 19(8): 1821 - 1825. [Abstract] [Full Text] [PDF]

				Y. Ohata, T. Harada, A. Fujii, S. Yoshida, T. Iwabe, and N. Terakawa Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M Mol. Hum. Reprod., July 1, 2001; 7(7): 665 - 670. [Abstract] [Full Text] [PDF]

				M. Tanikawa, T. Harada, M. Mitsunari, Y. Onohara, T. Iwabe, and N. Terakawa Expression of c-kit Messenger Ribonucleic Acid in Human Oocyte and Presence of Soluble c-kit in Follicular Fluid J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1239 - 1242. [Abstract] [Full Text]

				A. E. Pekary, J. M. Hershman, and L. Berg Tumor Necrosis Factor, Ceramide, Transforming Growth Factor-{beta}1, and Aging Reduce Na+/I- Symporter Messenger Ribonucleic Acid Levels in FRTL-5 Cells Endocrinology, February 1, 1998; 139(2): 703 - 712. [Abstract] [Full Text] [PDF]

				K. Sato, M. Miyakawa, N. Onoda, H. Demura, T. Yamashita, M. Miura, T. Kasajima, K. Yamazaki, and T. Obara Increased Concentration of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Cyst Fluid of Enlarging and Recurrent Thyroid Nodules J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1968 - 1973. [Abstract] [Full Text] [PDF]